| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 03/07/2002 | US20020028190 Compositions of non-ionic block copolymers to treat autoimmune, proliferative, and inflammatory diseases and methods of use thereof |
| 03/07/2002 | DE10042060A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10042059A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 03/07/2002 | DE10041428A1 Biphenylderivate Biphenyl |
| 03/07/2002 | DE10041423A1 Biphenylderivate Biphenyl |
| 03/07/2002 | DE10040783A1 AZA-Aminosäurederivate (Faktor X¶a¶-Inhibitoren 15) AZA-amino acid derivatives (factor inhibitors X¶a¶ 15) |
| 03/07/2002 | CA2421893A1 Phosphate derivatives as immunoregulatory agents |
| 03/07/2002 | CA2421503A1 Methods and compositions for inhibiting angiogenesis |
| 03/07/2002 | CA2421055A1 Co-crystal structure of monoclonal antibody 5c8 and cd154, and use thereof in drug design |
| 03/07/2002 | CA2420900A1 Thrombomodulin analogs for use in recovery of signal cord injury |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2420832A1 Methods and reagents for protease inhibition |
| 03/07/2002 | CA2420804A1 Pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors |
| 03/07/2002 | CA2420667A1 Quinoline-(c=o)-(di-,tri- and tetrapeptide) derivatives as caspase inhibitors |
| 03/07/2002 | CA2420591A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | CA2420286A1 7-oxo pyridopyrimidines as inhibitors of a cellular proliferation |
| 03/07/2002 | CA2420122A1 7-oxo pyridopyrimidines |
| 03/07/2002 | CA2420103A1 Modulation of fas and fasl expression |
| 03/07/2002 | CA2419841A1 Novel cd40:cd154 binding interruptor compounds and use thereof to treat immunological complications |
| 03/07/2002 | CA2419699A1 Gem-substituted .alpha. v .beta. 3 integrin antagonists |
| 03/07/2002 | CA2419399A1 Nucleoside derivatives for the treatment of hepatitis c |
| 03/07/2002 | CA2419249A1 Water-dispersible encapsulated sterols |
| 03/07/2002 | CA2418041A1 Pyrrolidine derivatives and their use as chymase inhibitor |
| 03/06/2002 | EP1184388A1 Sulphostin analogues and processes for the preparation of sulphostin and analogues thereof |
| 03/06/2002 | EP1184376A1 Novel heterocyclic carboxamide derivatives |
| 03/06/2002 | EP1184036A2 Heterocyclic compounds, their production and use as tachykinin receptor antagonists |
| 03/06/2002 | EP1183370A2 Human oxidoreductase proteins |
| 03/06/2002 | EP1183361A1 Gene therapy of pulmonary disease |
| 03/06/2002 | EP1183353A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 03/06/2002 | EP1183274A1 Method and compounds for inhibiting activity of serine elastases |
| 03/06/2002 | EP1183259A2 Azepinoindole derivatives, the production and use thereof |
| 03/06/2002 | EP1183258A1 Imidazo-containing heterocyclic compounds, their compositions and uses |
| 03/06/2002 | EP1183254A1 Substituted bicyclic heteroaryl compounds as integrin antagonists |
| 03/06/2002 | EP1183241A1 Spiroimidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 03/06/2002 | EP1183239A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 03/06/2002 | EP1183233A2 Bradykinin receptor antagonists |
| 03/06/2002 | EP1183047A2 Pharmaceutical preparation |
| 03/06/2002 | EP1183040A1 Therapeutic use of an inhibitor of a hedgehog or a hedgehog-related signalling pathway |
| 03/06/2002 | EP1183039A1 Pharmaceutical preparations of bioactive substances extracted from natural sources |
| 03/06/2002 | EP1183037A2 Methods and compositions for modulating immune response and for the treatment of inflammatory disease |
| 03/06/2002 | EP1183033A1 Pyrrolotriazine inhibitors of kinases |
| 03/06/2002 | EP1183023A1 Use of verapamil and verapamil derivatives for producing medicaments with an inhibiting effect on beta-glucuronidase in human tissue |
| 03/06/2002 | EP1183022A1 Method and composition for treating mammalian nasal and sinus diseases caused by inflammatory response |
| 03/06/2002 | EP1183019A2 Ace-2 inhibiting compounds and methods of use thereof |
| 03/06/2002 | EP1183014A1 Controlled release and taste masking oral pharmaceutical compositions |
| 03/06/2002 | EP1096944B1 Extracts of zanthoxylum bungeanum, pharmaceutical and cosmetic formulations containing them |
| 03/06/2002 | EP0946548B1 Novel heterocyclic substituted pyrrolidine amide derivatives |
| 03/06/2002 | EP0819122B1 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 03/06/2002 | EP0743945B1 Heterocyclic compounds and their preparation and use |
| 03/06/2002 | CN1339032A Reverse hydroxamate inhibitors of matrix metalloproteinases |
| 03/06/2002 | CN1339028A Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases |
| 03/06/2002 | CN1339025A Indole derivatives and their use as MCP-1 antagonists |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338929A Highly purified ethyl EPA and other EPA derivatives for psychiatric and neurological disorders |
| 03/06/2002 | CN1338928A Combinations of formoterol and a tiotropium salt |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338281A Prescriptions of 10 moxibustion medicines (for dermatopathy, venereal disease, sore and ilcer) |
| 03/06/2002 | CN1338280A Prescriptions of 12 moxibustion medicine (for beautifying face and hair and treating dermatopathy) |
| 03/06/2002 | CN1338279A Prescriptions of 10 moxibustion medicines (for rheumatalgia) |
| 03/06/2002 | CN1338277A Prescription of 11 moxibustion medicine (for obstetric and breast diseases) |
| 03/06/2002 | CN1338265A Far infrared medicinal composition |
| 03/06/2002 | CN1338264A Bafengjietong plaster |
| 03/06/2002 | CN1338262A Compound monkshood rhizome cream and its preparing process |
| 03/06/2002 | CN1080262C Novel substituted 4-(1H-benzimidazol-2-YL)[1,4] diazepanes useful for the treatment of allergic diseases |
| 03/06/2002 | CN1080260C Substituted indazole derivatives and their use as phosphodiesterase (PDE) type IV and tumor necrosis factor (TNF) inhibitors |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353117 Pyrazoline derivatives, their preparation and application as medicaments |
| 03/05/2002 | US6353092 Patched-2 polypeptide |
| 03/05/2002 | US6353026 Antiinflammatory agents with polymorphone neutrophils |
| 03/05/2002 | US6353024 Method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias with trimebutine |
| 03/05/2002 | US6353010 Enzyme inhibitors tumor necrosis factor and phosphodiesterase for antiinflammatory agents |
| 03/05/2002 | US6353007 Substituted 1-(4-aminophenyl)indoles and their use as anti-inflammatory agents |
| 03/05/2002 | US6353004 Peripherally acting anti-pruritic opiates |
| 03/05/2002 | US6352995 Spiro-quinuclidine derivatives, their preparation and use |
| 03/05/2002 | US6352990 CRF receptor antagonists and methods relating thereto |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 03/05/2002 | US6352832 Anti-CCR2 antibodies and methods of use therefor |
| 03/05/2002 | CA2215013C N-substituted indol-3-glyoxylamides having anti-asthmatic, antiallergic and immunosuppressant/immuno-modulating action |
| 03/05/2002 | CA2207574C Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products |
| 03/05/2002 | CA2049850C 4-substituted dihydropyrido[4,3-d]pyrimidines as analgesics and topical antiinflammatory agents for the treatment of skin disorders |
| 02/28/2002 | WO2002016638A1 METHOD FOR IDENTIFYING SUBSTANCES USEFUL FOR TREATING INFLAMMATION USING THE RESPONSE ELEMENT TO THE IλBα ROR RECEPTOR |
| 02/28/2002 | WO2002016615A2 Crystal structure of dimethylarginine dimethylaminohydrolase and arginine deiminase |
| 02/28/2002 | WO2002016584A2 Process for the preparation of neutrophil inhibitory factor |
| 02/28/2002 | WO2002016567A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/28/2002 | WO2002016436A2 ANTIBODIES TO HUMAN IL-1$g(b) |
| 02/28/2002 | WO2002016434A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION |
| 02/28/2002 | WO2002016394A1 Thioether-sulphamate steroids as steroid sulphatase inhibitors and anti-cancer compounds |
| 02/28/2002 | WO2002016393A1 17-aryl-linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016392A1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 02/28/2002 | WO2002016381A2 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | WO2002016370A1 1h-imidazopyridine derivatives |
| 02/28/2002 | WO2002016359A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | WO2002016353A1 Bicyclic heteroaromatic derivatives for the treatment of immune and inflammatory disorders |
| 02/28/2002 | WO2002016352A1 Quinazoline derivatives |
| 02/28/2002 | WO2002016348A1 Antiangiogenic bicyclic derivatives |
| 02/28/2002 | WO2002016327A1 Benzimidazoles and analogues and their use as neutrophil inhibitors |
| 02/28/2002 | WO2002016326A1 Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases |
| 02/28/2002 | WO2002016324A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |